ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

Delayed Data
As of May 24
 +0.62 / +2.45%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 30.00, with a high estimate of 60.00 and a low estimate of 21.00. The median estimate represents a +15.56% increase from the last price of 25.96.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 22.96%
Growthannually 1.89%


Growthquarterly 15.22%
Growthannually 30.83%
Key to the earnings and sales forecast charts.